Net profit of Medicamen Biotech declined 3.31% to Rs 1.46 crore in the quarter ended September 2024 as against Rs 1.51 crore during the previous quarter ended September 2023. Sales rose 2.76% to Rs 44.74 crore in the quarter ended September 2024 as against Rs 43.54 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales44.7443.54 3 OPM %11.8710.66 - PBDT4.564.29 6 PBT1.962.46 -20 NP1.461.51 -3 Powered by Capital Market - Live News

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live News

Medicamen Biotech announced that the Annual General Meeting (AGM) of the company will be held on 26 September 2024.Powered by Capital Market - Live News

Net profit of Medicamen Biotech declined 67.70% to Rs 1.35 crore in the quarter ended June 2024 as against Rs 4.18 crore during the previous quarter ended June 2023. Sales rose 2.65% to Rs 43.05 crore in the quarter ended June 2024 as against Rs 41.94 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales43.0541.94 3 OPM %7.9916.57 - PBDT3.336.37 -48 PBT1.564.68 -67 NP1.354.18 -68 Powered by Capital Market - Live News

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live News